CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of CAD 115.57 billion. The enterprise value is 215.69 billion.

Market Cap	115.57B
Enterprise Value	215.69B

Important Dates

The next estimated earnings date is Thursday, May 1, 2025.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.17%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.26B

Valuation Ratios

The trailing PE ratio is 17.41.

PE Ratio	17.41
Forward PE	n/a
PS Ratio	0.22
PB Ratio	1.06
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.93, with an EV/FCF ratio of 23.70.

EV / Earnings	32.49
EV / Sales	0.42
EV / EBITDA	9.93
EV / EBIT	19.37
EV / FCF	23.70

Financial Position

The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.09.

Current Ratio	0.81
Quick Ratio	0.56
Debt / Equity	1.09
Debt / EBITDA	5.30
Debt / FCF	13.11
Interest Coverage	2.71

Financial Efficiency

Return on equity (ROE) is 6.02% and return on invested capital (ROIC) is 3.19%.

Return on Equity (ROE)	6.02%
Return on Assets (ROA)	1.99%
Return on Invested Capital (ROIC)	3.19%
Return on Capital Employed (ROCE)	4.76%
Revenue Per Employee	2.06M
Profits Per Employee	25,583
Employee Count	300,000
Asset Turnover	1.47
Inventory Turnover	17.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.05% in the last 52 weeks. The beta is 0.57, so CVS Health's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-6.05%
50-Day Moving Average	16.37
200-Day Moving Average	14.63
Relative Strength Index (RSI)	46.46
Average Volume (20 Days)	984,540

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.71

Income Statement

In the last 12 months, CVS Health had revenue of CAD 533.31 billion and earned 6.64 billion in profits. Earnings per share was 5.27.

Revenue	533.31B
Gross Profit	70.86B
Operating Income	11.54B
Pretax Income	8.85B
Net Income	6.64B
EBITDA	18.15B
EBIT	11.54B
Earnings Per Share (EPS)	5.27

Full Income Statement

Balance Sheet

The company has 15.82 billion in cash and 119.31 billion in debt, giving a net cash position of -103.49 billion.

Cash & Cash Equivalents	15.82B
Total Debt	119.31B
Net Cash	-103.49B
Net Cash Per Share	n/a
Equity (Book Value)	108.96B
Book Value Per Share	86.28
Working Capital	-22.97B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.10 billion and capital expenditures -4.00 billion, giving a free cash flow of 9.10 billion.

Operating Cash Flow	13.10B
Capital Expenditures	-4.00B
Free Cash Flow	9.10B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 13.29%, with operating and profit margins of 2.16% and 1.24%.

Gross Margin	13.29%
Operating Margin	2.16%
Pretax Margin	1.66%
Profit Margin	1.24%
EBITDA Margin	3.40%
EBIT Margin	2.16%
FCF Margin	1.71%

Dividends & Yields

CVS Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	73.10%
Buyback Yield	2.17%
Shareholder Yield	2.17%
Earnings Yield	5.74%
FCF Yield	7.88%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.11. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.11
Piotroski F-Score	n/a